Escitalopram More Effective Than Prozac in Preventing Depression Relapse, Large Analysis Shows

A recent meta-analysis, encompassing data from 232 clinical trials involving over 64,000 adult patients, concluded that certain antidepressants demonstrate superior efficacy in preventing the recurrence of depressive episodes. The findings highlight escitalopram, sertraline, and agomelatine as leading treatments in this regard.

Specifically, escitalopram was found to be more effective than fluoxetine (Prozac) in preventing relapse, a crucial aspect of managing long-term depression. This analysis focused on how well various medications sustained remission and prevented subsequent depressive episodes, rather than just initial symptom reduction.

The study, which examined 21 different antidepressants, reinforces the understanding that while many medications can initially alleviate depressive symptoms, their ability to prevent relapse varies significantly. This evidence provides valuable insight for clinicians considering long-term treatment strategies for depression.